To reduce the risk of experiencing side effects, the recommended initial adult dose of tizanidine is 2 mg up to 3 times daily.
Coadministration may result in large increases in alfuzosin serum concentrations, which could cause adverse events such as hypotension.
The mechanism of action of metaxalone in humans has not been established, but may be due to general central nervous system depression.
Thalidomide frequently causes drowsiness and somnolence and may enhance the sedative activity of methocarbamol.
Alfuzosin lowers blood pressure and may cause dizziness or fainting, especially when you first start taking it.
The ability of the body to absorb tizanidine if taken with food differs if taken without food.